interview decision makers

How long has the organization tried to
address this issue? What measures have been taken to address this issue in the past? What
future steps have been planned to address this issue? What problems does the organization
foresee as blocks to addressing this issue? How did your perception of the financial issue
differ from the perception of those who are actually working on finances in the
organization? Take the information you have learned from the interviews and create a 2-3
page paper with your findings. Be sure to explain the roles of the individuals you
interviewed. As you reflect on the results of the interview, use current literature to further
explain the important points.

Project- interview decision makers

Over the past five years it has been noted that the budgeting of treatment of diabetes at St.
Patrick’s Hospital has been a major financial issue. This has been reported to affect about 300
patients who are usually referred to other hospitals. As a nurse who works for the hospital which
is a public hospital, I was tasked with the task of interviewing several staff members from the
hospital concerning this issue.
For the purposes of the interview, I chose two staff members to interview, that is the
Chief finance officer of the hospital whose main role is to oversee the allocation of funds to
various departments and the doctor in charge of chronic diseases department whose main
financial role is to oversee the usage of funds allocated for chronic diseases treatment .
According to the chief finance officer, the hospital has had a shortage of funds when it comes to
the budgeting of treatment of diabetes for the past five years. The hospital mainly depends on the
government for funds to be used in buying of the drugs to be used in the treatment of diabetes of
which the funds are insufficient. The chief finance officer had two main reasons to explain the
reason why the funds are insufficient. Firstly, he noted that the drugs have become costly

compared to how they were five years ago. He added that the government has continued to
allocate the same amount of money that it used to allocate five years ago that is $100 million
without putting into consideration the appreciating price which is at an approximated $150
million. Out of the $100 million, the hospital is required to use 0.05% for diabetes treatment. The
finance officer furthers on by stating that 0.1% is required for full diabetes treatment in the
hospital. A quick check on this reveals that according to a research done in 2013, it was
discovered that diabetes drugs are the most expensive compared to any other drugs and that in
between 2012 and 2013, the price had risen by 14% and that the price will continue to rise
between 10% and 13% annually through 2016 with $245 billion being used in the USA for
diabetes in 2013. The same was reflected in traditional medications such as diabetes therapies
whereby the cost had risen by 0.5% between 2012 and 2013. (Chawla, 2014, pg 7)
Secondly, the chief finance officer was able to identify the tremendous increasing number
of diabetic patients over the past five years as being the other reason as to why budgeting of
diabetes has been a major financial issue. Interviewing the doctor in charge of chronic diseases
was able to give us salient insight on this point. The doctor who is a member of the association
was able to avail to us crucial statistics from the American Diabetes Association. According to
the association, in 2010, there were 25.8 million reported cases of diabetes in the USA and in
2012, the number had risen to 29.1 million and he mostly associated this to the living style of the
American People. (Chawla, 2014, pg 7)
All in all, the chief finance officer, who although acknowledges that nothing much has
been done states that in the past they have tried to address this issue through sourcing of more
funds from the government which has proven to be futile.

The hospital has taken several measures to address this issue; the doctor states that it has
organized an annual marathon in conjunction with the American Diabetes Association. The
marathon is aimed at raising proceeds that will be used in the treatment of diabetes. Time limit
may become a barrier in performing this measure since a lot of time is required in the organizing
of a successful marathon that will raise sufficient funds. The chief finance officer reveals that the
hospital is sourcing funds from other alternative organizations such as the World Health
Organization but he also states that these organizations might fail to corporate and this may be a
barrier. The chief finance officer also states that funds allocated to other departments will have to
be cut by 2% which will be directed to diabetes treatment. (In Dunham-Taylor & In Pinczuk,
2015, pg 224)
In conclusion, before the interview, my perception on the best way in addressing the
financial issue was through regulating the number of diabetic patients but through the interview I
was able to learn that that was practically impossible but rather the best method was through
raising more funds.


Chawla, R. (2014). Manual of diabetes care.
In Dunham-Taylor, J., & In Pinczuk, J. Z. (2015). Financial management for nurse
managers: Merging the heart with the dollar.

Looking for Discount?

You'll get a high-quality service, that's for sure.

To welcome you, we give you a 20% discount on your All orders! use code - NWS20

Discount applies to orders from $30
All Rights Reserved,
Disclaimer: You will use the product (paper) for legal purposes only and you are not authorized to plagiarize. In addition, neither our website nor any of its affiliates and/or partners shall be liable for any unethical, inappropriate, illegal, or otherwise wrongful use of the Products and/or other written material received from the Website. This includes plagiarism, lawsuits, poor grading, expulsion, academic probation, loss of scholarships / awards / grants/ prizes / titles / positions, failure, suspension, or any other disciplinary or legal actions. Purchasers of Products from the Website are solely responsible for any and all disciplinary actions arising from the improper, unethical, and/or illegal use of such Products.